Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Industry News and Resources » Industry Providers

Industry Provider Profiles
Hammersmith Medicines Research (HMR)

Company Type Services

Contact Information

Dr Malcolm Boyce
Hammersmith Medicines Research (HMR)
Cumberland Avenue
London NW10 7EW
UK
+44 (0)20 8961 4130
+44 (0)20 8961 8665 (fax)
mboyce@hmrlondon.com
www.hmrlondon.com

Contact Company

Company Overview

HMR is a Contract Research Organisation (CRO). We specialise in and can provide a full service for phase 1 and early phase 2 studies. Our premises are spacious (5800 m²) and have 100 beds, a sleep unit for polysomnography, facilities for volunteers, laboratories, a pharmacy, including an aseptic unit and radiopharmacy, and offices. We have 150 staff – 8 physicians, 35 nurses or nurse graduates, and 95 graduates or PhD. We have done over 550 studies since 1993. HMR is the largest CRO of its kind in Europe.

Services

Our services include:

  • Reviewing the client's preclinical research data, plus any relevant scientific and medical literature, then advising on human studies
  • Writing the study protocol
  • Developing methods of assessing the efficacy of medicines
  • Designing and producing CRFs
  • Writing the Informed Consent Form
  • Application to Research Ethics Committees
  • Recruiting and screening volunteers or patients
  • Carrying out the study
  • Repackaging and reconstituting investigational medicinal product
  • Laboratory safety tests of blood and urine,and biomarkers
  • Data management and statistical analysis
  • Pharmacokinetic analysis
  • Clinical, statistical and pharmacokinetic reports

Scope of Our Services

General

Most of our studies involve assessment of drug handling and effects in healthy volunteers or patients after oral, intravenous or topical administration. We offer a wide range of types of study:

  • First administration to man - single and repeated dose
  • Pharmacodynamic studies - single and repeated dose, using established or new methods
  • Safety and tolerability testing - single and repeated dose
  • Pharmacokinetic studies - single and repeated dose
  • Metabolic studies - 'cold' and radiolabelled
  • Drug interactions - drug/drug; drug/food; drug/alcohol

Biotechnology studies

We have done studies with novel proteins, peptides, cytokines or vaccines, mainly produced by recombinant techniques, or genetically modified micro-organisms. Our premises are approved by the UK Health & Safety Executive for studies with genetically modified micro-organisms, types 1 and 2.

Pharmacodynamic studies

We offer a wide range of methods of measuring actions of drugs on the human body: Cardiovascular

  • 41 beds with central ECG monitoring (SpaceLabs), including continuous electronic and hard copy ECG recording, arrhythmia detection
  • Telemetry (SpaceLabs); ECG monitoring of 24 channels by radio link throughout premises
  • Microprocessor-assisted standard ECG
  • Impedance cardiography
  • Doppler aortic velography
  • Laser Doppler flowmetry
  • Forearm blood flow
  • 24 h ambulatory ECG
  • 24 h ambulatory blood pressure monitoring
  • Exercise ECG
  • Passive tilt testing
  • Catecholamine and prostanoid agonist/antagonist studies

Central nervous system

  • Psychomotor testing
  • Coordination tests
  • Cognitive function assessment
  • Scopolamine model of dementia
  • Analgesia assessment
  • Body sway
  • Saliva flow rate
  • 5-HT1A receptor mediated function tests
  • EEG and polysomnography
  • PET (in collaboration with the Cyclotron Unit, Hammersmith Hospital)

Respiratory

  • Peak expiratory flow rate
  • Minute volume
  • Standard spirometry
  • Computer-assisted spirometry
  • Pulse oximetry (12 beds)
  • End tidal pCO2
  • Transcutaneous pO2
  • Bronchoscopy and broncho-alveolar lavage
  • Histamine, methacholine and AMP challenge
  • Allergen challenge
  • Exhaled NO assay
  • Sputum analysis
  • Acoustic rhinometry
  • Leucocyte flow cytometry

Gastro-intestinal

  • Intragastric and oesophageal ambulatory pH monitoring (24 h)
  • Gastro-intestinal transit time
  • Intragastric infusion of drug
  • Intrajejunal drug administration
  • Faecal red blood cell loss (using chromium-51 labelled red cells)
  • Upper gastro-intestinal endoscopy
  • Pentagastrin- or histamine-stimulated acid secretion
  • Gastric emptying using paracetamol kinetics

Renal

  • Chromium-51 EDTA method for glomerular filtration rate
  • Iodine-125 Hippuran method for effective renal plasma flow
  • Urinary transferrin, microalbumin and α1-microglobulin to assess potential nephrotoxicity
  • Urinary enzyme assay
  • Renin and angiotensin assessments

Ocular

  • Intraocular pressure by non-contact or applanation tonometry
  • Slit lamp examination
  • Pupillometry: static & dynamic, by video infrared

Haematological

  • Bleeding time
  • Platelet aggregometry
  • Red blood cell deformability
  • Coagulation studies
  • Cytokine assay
  • Assay of red and white blood cell precursors
  • FACS

Dermatological

  • Transdermal bioavailability
  • Cutaneous irritancy and sensitisation
  • Extracellular fluid and skin drug pharmacokinetics
  • Histamine, 5-HT or substance P intradermal tests
  • Allergen tests

Analysis of drug concentrations

  • Gas chromatography
  • HPLC
  • ELISA
  • LC/MSMS
  • Radioimmunoassay
  • Drug screening (eg alcohol, benzodiazepines, cocaine, opiates, amphetamines, cannabis)

Pharmacokinetic analysis

  • Derivation of all parameters
  • Kinetic modelling

Analysis of drug concentrations

We collaborate with the best commercial units, or with the Analytical Unit, St George's Hospital, London, a GLP-registered laboratory with a full range of analytical methods for assay of drug concentrations.

Data management, statistics, report writing and quality services

We manage, analyse and report data generated within or outside the company. We use ClinPlus, a commercial SAS-based data management system. SAS is our main software for statistical analyses. We prepare study reports in accord with ICH Guidelines or the client's standard operating procedures. We provide an independent quality service: we audit from source data to statistical output and from statistical output to the study report. Our ISO 9001 quality management system is based on GCP, & comprises a quality manual, 17 quality system procedures, and 700 standard operating procedures.

Pharmacy

Our GMP-compliant pharmacy manufactures non-sterile, sterile and radioactive IMPs. We have had MIA(IMP) since 2004, and are licensed for radiolabelled studies. We have 3 QPs.

Analytical laboratory

OurCAP-accredited, ultramodern pathology laboratory offers a full range of biochemistry and haematology tests, urinalysis, and an extensive range of biomarkers using methods that include platelet aggregometry and FACS

Resuscitation facilities

We have full facilities for cardiopulmonary resuscitation including cardiac defibrillationWe have a 24-hour resuscitation team, resident MO, and emergency alarms throughout. Our wards are close to the Intensive Therapy and Coronary Care Units of Central Middlesex Hospital.

Markets and Customers

Our markets are worldwide. To date we have worked for companies in Austria, Belgium, Canada, Denmark, France, Germany, Holland, Hungary, Israel, Italy, Japan, Korea, Spain, Sweden, Switzerland, UK and USA. Our customers are large national or international pharmaceutical companies and smaller biotechnology or biopharmaceutical companies. Over 60% of our work is from companies outside the UK.

Achievements

1998: The Queen's Award for Export Achievement

1999: ISO 9001 accreditation

1999: UK Fast Track 100 company (one of the 100 fastest growing UK companies)

2002: The Queen's Awards for Enterprise: International Trade

2002: College of American Pathologists accreditation

2003: Royal Pharmaceutical Society registration

2004: National Training Award

2004: Manufacturer's Authorisation for IMP

2008: MHRA Phase 1 Supplementary Accreditation

2010: CIR accreditation

Volunteers

  • Dedicated team of 10 recruiters
  • Special populations, eg elderly, post-menopausal women, Japanese volunteers for ‘bridging studies’
  • Patient volunteers for special studies, eg asthma, allergic rhinitis, herpes virus infection, benign prostatic hypertrophy, diabetes, male erectile dysfunction and migraine
  • Internet-based system (TOPS) to prevent subjects from taking part in studies too frequently

Contact Information

Dr Malcolm Boyce
Hammersmith Medicines Research (HMR)
Cumberland Avenue
London NW10 7EW
UK
+44 (0)20 8961 4130
+44 (0)20 8961 8665 (fax)
mboyce@hmrlondon.com
www.hmrlondon.com

Contact Company

If you are interested in contacting this company, please complete and submit the form below. A representative from the company will follow up with you.

Name:  
Address:
City:
State:
Country:
Phone:
Email:  
Message: